Gastro-Intestinal (GI) cancer is a term for the group of cancers that affect the digestive system – where food passes through our bodies and is processed by various organs.

GI cancers include those of the oesophagus, gallbladder, liver, pancreas, stomach and bowel (the bowel includes the small intestine, large intestine or colon, and rectum).

GI cancer is the most common form of cancer. In Australia, over 12,000 people die of a cancer of the digestive system each year  – 33 a day, almost twice the total for breast and prostate cancers combined. GI cancers don’t discriminate between men and women.

Just over half the people diagnosed with a GI cancer survive for more than five years. Some GI cancers have even lower survival rates – stomach cancer just 27% and pancreatic cancer a shocking 6%.

Great work in breast and prostate cancer awareness has raised their survival rates to over 90% – we need to do the same with GI cancers.

The GI Cancer Institute aims to raise awareness about digestive cancers, and raise funds for world-leading clinical trials to improve treatments. Treatment for GI cancer depends on the type of cancer, the stage of its development, and other health factors. Treatment commonly includes surgery, chemotherapy and radiation therapy. The best way to improve these treatments is through clinical trials.

Donate now and support the GI Cancer Institute to raise funds for research and clinical trials to improve treatments for GI cancers.